Anal cancer treated with radio-chemotherapy: Correlation between length of treatment interruption and outcome

International Journal of Colorectal Disease

Volumn 24, Issue 12, 2009, Pages 1421-1428

  Janssen, Stefan ^a   Meier zu Eissen, Jürgen ^b   Kolbert, Gerd ^b   Bremer, Michael ^a   Karstens, Johann Hinrich ^a   Meyer, Andreas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Sophienklinik Hannover ^*  (Germany)

Author keywords

Anal cancer; Outcome; Radio chemotherapy; Toxicity

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COLOSTOMY; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG FATALITY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; ILEUM DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; SKIN TOXICITY; THERAPY DELAY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RADIOTHERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350426027     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0775-2     Document Type: Article

References (30)

1. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR (2004) Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101:281-288
2. Dahling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA et al (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101:270-280
3. Poletti PA, Halfon A, Marti MC (1998) Papillomavirus and anal carcinoma. Int J Colorectal Dis 13:108-111
4. Varnai AD, Bolmann M, Griefingholt H, Speich N, Schmitt C et al (2006) HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis 21:135-142
5. Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum 17:354-356
6. Ryan DP, Compton CC, Mayer RJ (2000) Carcinoma of the anal canal. N Engl J Med 342:792-800
7. Bartelink H, Roelofson F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049
8. UKCCCR Anal Cancer Trial Working Party (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348:1049-1054
9. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14:2527-2539
10. Cummings BJ, Brierley JD (2004) Anal canal. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK (eds) Principles and practice of radiation oncology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1630-1648
11. Graf R, Wust P, Hildebrandt B, Gogler H, Ullrich R, Herrmann R et al (2003) Impact of overall treatment time on local control of anal cancer treated with radio-chemotherapy. Oncology 65:14-22
12. Deniaud-Alexandre E, Touboul E, Tiret E (2003) Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 56:1259-1273
13. Meyer A, Meier zu Eissen J, Karstens JH, Bremer M (2006) Chemotherapy in patients with anal cancer: Impact of length of unplanned treatment interruption on outcome. Acta Oncol 45:728-735
14. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN (1991) Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:1115-1125
15. Widder J, Kastenberger R, Fercher E, Schmid R, Langendijk JA, Dobrosky W et al (2008) Radiation dose associated with local control in advanced anal cancer: Retrospective analysis of 129 patients. Radiother Oncol 87:367-375
16. Fowler JF, Lindstrom MJ (1992) Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23:457-467
17. Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H et al (1993) Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 27:1051-1056
18. Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223-231
19. Vuong T, Devic S, Belliveau P, Muanza T, Hegyi G (2003) Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: Results of a phase II study. Int J Radiat Oncol Biol Phys 56:823-831
20. Peiffert D, Bey P, Pernot M, Guillemin F, Luporsi E, Hoffstetter S et al (1997) Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 37:313-324
21. Weber DC, Kurtz J, Allal AS (2001) The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50:675-680
22. Ceresoli GL, Ferreri AJ, Cordio S, Villa E (1998) Role of dose intensity in conservative treatment of anal canal carcinoma. Report of 35 cases. Oncology 55:525-532
23. Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 39:651-657
24. Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM (1997) The impact of treatment factors of local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 79:2329-2335
25. Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ et al (2003) Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Eur J Cancer 39:45-51
26. Mai SK, Welzel G, Hermann B, Bohrer M, Wenz F (2008) Long-term outcome after combined radiochemotherapy for anal cancer - retrospective analysis of efficacy, prognosis factors, and toxicity. Onkologie 31:251-257
27. Konski A, Garcia M, John M, Krieg R, Pinover W, Myerson R et al (2008) Evaluation of planned treatment breaks during radiation therapy for anal cancer: Update of RTOG 92-08. Int J Radiat Oncol Biol Phys 72:114-118
28. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, Thomas CR et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. JAMA 299:1914-1921
29. Voung T, Kopek N, Durcruet T, Portlance L, Faria S, Bahoric B et al (2007) Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys 67:1394-1400
30. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB et al (2008) Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience. J Clin Oncol 25:4581-4586